Mental Health

The Sigourney Trust Issues Call For Entries Of Psychoanalytic Work Eligible To Win The Sigourney Award-2022

Applications For The Sigourney Award-2022 Accepted March 1 Through July 31  SEATTLE, March 1, 2022 /PRNewswire/ -- Each year The Sigourney Trust honors up to four individuals, groups or organizations with an independent prize,The Sigourney Award. This prestigious international award honors recent...

2022-03-01 22:15 2250

The journey from Good to Great: Camly Academy successfully launched in the U.S market

HO CHI MINH CITY, Vietnam, Feb. 23, 2022 /PRNewswire/ -- Recently, Camly Academy of Camly Group successfully held an event to launch an educational platform in the US market with the topic: "Self-Education for Happiness: Good to Great" onFebruary 22, 2022 to announce action mission towards sustai...

2022-02-23 14:49 3131

Alterity Therapeutics Announces Publication Demonstrating that ATH434 is Neuroprotective in Animal Model of Parkinsonian Disorder in the Journal of Parkinson's Disease

MELBOURNE, Australia, Jan. 28, 2022 /PRNewswire/ -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company"), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today announced that data in an animal model of Multiple S...

2022-01-28 20:08 3077

Dr. Ivan Puah Highlights The Significant Impact Of Covid That Changes Our Priority In Life

SINGAPORE, Jan. 11, 2022 /PRNewswire/ -- The current pandemic has raised more awareness of the importance of health and better care of oneself. Dr.Ivan Puah, Medical Director at Amaris B. Clinic shares how people's lifestyles and priorities have changed since Covid-19 started. 01. Losing we...

2022-01-11 06:44 2723

Luye Pharma Releases Top-Line Results from a Phase II Clinical Trial of Its New Antidepressant Ansofaxine Hydrochloride Extended-Release Tablets

CHONGQING, China, Dec. 23, 2021 /PRNewswire/ -- Luye Pharma Group today released the encouraging top-line results from a Phase II clinical trial of its new antidepressant, Ansofaxine Hydrochloride Extended-Release Tablets (LY03005), at the 19th National Psychiatry Conference of the Chinese Medica...

2021-12-23 16:23 4084

2021 WISE Summit Concludes

Thousands of thinkers, innovators, and practitioners joined the event in-person and online to help build the next generation of changemakers DOHA, Qatar, Dec. 16, 2021 /PRNewswire/ -- The 2021 WISE Summit has marked a seminal moment in education change. In one of the biggest global education eve...

2021-12-16 09:57 986

New App Strengthens Human Connection

PARIS, Dec. 14, 2021 /PRNewswire/ -- Heallo, a new smartphone application focused on strengthening personal human connections, launchesTuesday, December 14. Named to combine healing with saying "hello," Heallo  allows users to share feelings and be present for one anothe...

2021-12-14 07:00 2902

AXA Hong Kong launched exclusive mind health network and online counselling service for Employee Benefits customers

HONG KONG, Dec. 8, 2021 /PRNewswire/ -- As a leading Employee Benefits insurance provider, AXA Hong Kong (AXA) continuously enhances its services to working individuals with a commitment to safeguarding all aspects of their physical and mental wellbeing. To enhance mental health support and to ma...

2021-12-08 18:00 3324

U.S. FDA Grants Bionomics Fast Track Designation to BNC210 for the Acute Treatment of Social Anxiety Disorder and Other Anxiety Related Disorders

ADELAIDE, Australia, Dec. 1, 2021 /PRNewswire/ -- Bionomics Limited (ASX:BNO, OTCQB:BNOEF) (Bionomics or Company), a clinical-stage biopharmaceutical company, is pleased to announce that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to the BNC210 development progr...

2021-12-01 19:00 3560

Holmusk and Charité - Universitätsmedizin Berlin Enter a Strategic Collaboration to Drive Precision Psychiatry Using Novel Real-World Data

BERLIN, Nov. 23, 2021 /PRNewswire/ -- Holmusk, a leading global data science and digital health company building the world's largest Real-World Evidence (RWE) platform for mental health, has signed a Memorandum of Understanding with Charité - UniversitätsmedizinBerlin, Department of Child and Ado...

2021-11-23 14:00 3724

The Sigourney Award-2021 Honors Three Recipients With Distinguished International Prize for Advancing Psychoanalytic Thought

SEATTLE, Nov. 18, 2021 /PRNewswire/ -- The Sigourney Award annually rewards achievements that advance psychoanalytic thought and practice with international recognition and a substantial cash prize. This year, a panel of distinguished judges evaluated applications from five continents for The Si...

2021-11-18 21:14 2332

Marking One Year Milestone, ADDI Expands Access to Global Data for Alzheimer's Researchers

Organization saw growth in AD Workbench users, data partners, and patient datasets from across the globe, including from low- and middle-income countries  SEATTLE, Nov. 17, 2021 /PRNewswire/ -- Today, the Alzheimer's Disease Data Initiative (ADDI) marked one year of transforming how Alzheimer's d...

2021-11-17 19:00 3795
1 ... 1112131415